Gardiner Harris. Back to the Lab: Merck to shed Medco, its drug-benefits unit, in bid to boost stock – Company is under pressure as five major products go off patent – resisting calls for a merger // The Wall Street Journal, January 29, 2002; Merck Announces Plans to Divest its PBM Subsidiary // Drug Marketing, February 6, 2002.